ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of July

July 25, 2014

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

CCOP Budget Needs Hefty Increase To Fund 55 Awards At Requested Levels, Yates Says

January 30, 1987

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006